HanBio Therapeutics
PrivateLast Round
Series A
Jan 28, 2022
Company Overview
HanBio Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. It was founded in 2021.
HanBio Therapeutics is a biotechnology company that researches and develops transformative medicines for serious diseases, including bispecific antibodies and other biopharmaceutical products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HanBio Therapeutics Comparables
Compare HanBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 78% | |
| Wuhan YZY Biopharma Co Ltd | 77% | |
| Sino Biopharmaceutical | 76% |
For institutional investors. Book with your work email.
HanBio Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
HanBio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A |
| Hankang Capital | Series A |
HanBio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HanBio Therapeutics's valuation, stock price, and market status.
Is HanBio Therapeutics a public or private company?
HanBio Therapeutics is a private company.
What is the current stock price of HanBio Therapeutics?
HanBio Therapeutics is a private company, so its shares have no public market price. Caplight tracks HanBio Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HanBio Therapeutics worth (valuation)?
Valuation information for HanBio Therapeutics is not publicly available.
Can I buy HanBio Therapeutics stock?
HanBio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HanBio Therapeutics's last funding round?
HanBio Therapeutics's most recent funding round was Series A on January 28, 2022.
Who are the main investors in HanBio Therapeutics?
Key investors in HanBio Therapeutics include OrbiMed, Hankang Capital.
Will HanBio Therapeutics IPO soon?
No public IPO plans have been announced for HanBio Therapeutics.
How can I track HanBio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in HanBio Therapeutics's shares on secondary markets.